The purpose of this research study is to evaluate the effectiveness and safety of a new treatment for achalasia of the lower esophageal sphincter. The esophagus is my food tube, and the muscle called a sphincter separates this tube from my stomach. Achalasia means that this sphincter muscle is too tight and fails to relax, so food does not pass properly into my stomach. As a result, I may experience difficulty swallowing, regurgitation, and weight loss. The new treatment being studies compares two different doses of botulinum toxin type A (Bo Tox(R)) to keep the sphincter open. This procedure involves injecting Bo Tox(R) into the sphincter muscle to open it. This procedure has been studied by Dr. Pasricha in patients with achalasia, in which Bo Tox(R) 80 units was injected into their esophageal sphincter during an endoscopy. After six months, 65% of the patients had experienced relief and still did not have their achalasia symptoms. After 1 year, 424 of the patients did not have symptoms. It is thought that using Bo Tox(R) will provide a safer and easier alternative to the current treatments. The current treatments for achalasia include balloon dilation (widening) of the esophageal sphincter, or surgery. This study will also determine whether using Bo Tox(R) in higher doses will cause toxicity (overdose), and will relieve the symptoms of achalasia for longer time periods. Botulinum toxin type A (Bo Tox(R)) is a product cultured from Clostridium botulinum, a toxin which when found in nature is known to be poisonous, and causes muscle paralysis. However, this preparation has been specially prepared for use as a medicine, and is commonly used to treat patients who have eye problems, such as droopy eyelids, for which has FDA approval. The use of Bo Tox(R) is not approved by the Food and Drug Administration (FDA) for use in achalasia, but it is used to treat this condition at some medical centers.

Project Start
1999-12-01
Project End
2000-11-30
Budget Start
1998-10-01
Budget End
1999-09-30
Support Year
38
Fiscal Year
2000
Total Cost
$34,211
Indirect Cost
Name
University of Texas Medical Br Galveston
Department
Type
DUNS #
041367053
City
Galveston
State
TX
Country
United States
Zip Code
77555
Gelman, Benjamin B; Endsley, Janice; Kolson, Dennis (2018) When do models of NeuroAIDS faithfully imitate ""the real thing""? J Neurovirol 24:146-155
Mourtakos, S P; Tambalis, K D; Panagiotakos, D B et al. (2017) Association between gestational weight gain and risk of obesity in preadolescence: a longitudinal study (1997-2007) of 5125 children in Greece. J Hum Nutr Diet 30:51-58
Ramanujam, V-M S; Nayeem, Fatima; Anderson, Karl E et al. (2017) Riboflavin as an independent and accurate biomarker for adherence in a randomized double-blind and placebo-controlled clinical trial. Biomarkers 22:508-516
Laffer, Cheryl L; Scott 3rd, Robert C; Titze, Jens M et al. (2016) Hemodynamics and Salt-and-Water Balance Link Sodium Storage and Vascular Dysfunction in Salt-Sensitive Subjects. Hypertension 68:195-203
Hosoki, Koa; Ying, Sun; Corrigan, Christopher et al. (2015) Analysis of a Panel of 48 Cytokines in BAL Fluids Specifically Identifies IL-8 Levels as the Only Cytokine that Distinguishes Controlled Asthma from Uncontrolled Asthma, and Correlates Inversely with FEV1. PLoS One 10:e0126035
Murai, Hiroki; Okazaki, Shintaro; Hayashi, Hisako et al. (2015) Alternaria extract activates autophagy that induces IL-18 release from airway epithelial cells. Biochem Biophys Res Commun 464:969-974
Diaz, Eva C; Herndon, David N; Porter, Craig et al. (2015) Effects of pharmacological interventions on muscle protein synthesis and breakdown in recovery from burns. Burns 41:649-57
Tuvdendorj, Demidmaa; Chinkes, David L; Bahadorani, John et al. (2014) Comparison of bolus injection and constant infusion methods for measuring muscle protein fractional synthesis rate in humans. Metabolism 63:1562-7
Sallam, Hanaa S; McNearney, Terry A; Chen, Jiande D Z (2014) Acupuncture-based modalities: novel alternative approaches in the treatment of gastrointestinal dysmotility in patients with systemic sclerosis. Explore (NY) 10:44-52
Petersen, John R; Stevenson, Heather L; Kasturi, Krishna S et al. (2014) Evaluation of the aspartate aminotransferase/platelet ratio index and enhanced liver fibrosis tests to detect significant fibrosis due to chronic hepatitis C. J Clin Gastroenterol 48:370-6

Showing the most recent 10 out of 465 publications